Riskpilot← Back to searchSign inGet full accessNestInvest 3 ApS
APSActiveCVR 40975179Hejrevej 39, 1.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 2019— employees
Revenue 2024
DKK 5,4M
+10% vs 2023
EBITDA margin
100.0%
+10% vs 2023
Equity ratio
66.5%
Financial strength
Net profit 2024
DKK 4,2M
+10% vs 2023
| Revenue | DKK 5,4M | +10% |
| EBITDA | DKK 5,4M | +10% |
| Net profit | DKK 4,2M | +10% |
| Total assets | DKK 6,9M | +6% |
| Equity | DKK 4,6M | +11% |
| Employees | — | — |
Legal name
NestInvest 3 ApS
CVR number
40975179
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
29. november 2019
Share capital
DKK 40.000
Employees
—
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Address
Hejrevej 39, 1.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3.875 | 5.306 | 5.034 | 4.913 | 5.398 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 |
| EBITDA | 3.875 | 5.306 | 5.034 | 4.913 | 5.398 |
| Depreciation & amort. | -32 | -27 | -34 | -34 | -34 |
| EBIT | 3.842 | 5.279 | 5.000 | 4.879 | 5.365 |
| Net financials | -24 | 73 | -12 | 40 | 68 |
| Profit before tax | 3.818 | 5.352 | 4.988 | 4.919 | 5.433 |
| Tax | 840 | 1.177 | 1.097 | 1.082 | 1.195 |
| Net profit | 2.978 | 4.175 | 3.891 | 3.837 | 4.237 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 4.464 | 13.969 | 6.662 | 6.434 | 6.851 |
| Equity | 3.018 | 4.393 | 4.283 | 4.120 | 4.558 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1.442 | 9.568 | 2.367 | 2.298 | 2.275 |
| Total debt | 1.442 | 9.568 | 2.367 | 2.298 | 2.275 |
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
20202024
Equity ratio
66.5%
This company
38.2%
Market median
+74% vs market
20202024
Return on equity
93.0%
This company
18.4%
Market median
+405% vs market
20202024
Net profit margin
78.5%
This company
8.1%
Market median
+869% vs market
20202024
Asset turnover
0.79×
This company
1.12×
Market median
-29% vs market
20202024
Debt / equity
0.50×
This company
0.62×
Market median
+19% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2019-11-29 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
LM Chief Executive Officer | Chief Executive Officer | 2019 |
MR Management | Management | 2019 |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2019 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
POMALA HOLDING ApS
NestInvest 3 ApS Board members of NestInvest 3 ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Mark Poulsen | Chief Executive Officer | 0 companies |
| Mads Renlef Henningsen | Management | 0 companies |